Evaluation Only. Created with Aspose.PDF. Copyright 2002-2021 Aspose Pty Ltd.
Journal of Natural Products
pubs.acs.org/jnp
Note
Corp.). Reagents and solvents used in this study were commercially
available (Concord Tianjin).
spectra, see Table 1; HRESI(+)MS m/z 509.3123 [2M + Na]+ (calcd
for C32H42N2O2Na, 509.3138).
2-(E-3-Methylpent-2-enyl)-4-quinolone (3): colorless solid; UV−
vis (CH3OH) λmax (log ε) 235 (2.11), 315 (1.59), and 328 (1.54)
nm; 1H NMR (methanol-d4, 600 MHz) and 13C NMR (methanol-d4,
150 MHz) spectra, see Table 1; HRESI(+)MS m/z 228.1380 [M +
H]+ (calcd for C15H18NO, 228.1383).
2-Benzyl-4-quinolone (4): colorless solid; UV−vis (CH3OH) λmax
(log ε) 235 (2.13), 315 (1.42), and 328 (1.37) nm; 1H NMR
(methanol-d4, 600 MHz) and 13C NMR (methanol-d4, 150 MHz)
spectra, see Table 1; HRESI(+)MS m/z 236.1066 [M + H]+ (calcd
for C16H14NO, 236.1070).
Microbial Strains. The microbial strain BD06-03 was isolated
from a soil sample collected from a park in Baoding City (Hebei
Province, China) at GPS coordinates 38.8747 N; 115.5349 E. The
species of the microbial strain BD06-03 were identified by 16S rDNA
sequence analysis as Pseudomonas aeruginosa (Figure S1), and the
sequence was submitted to GenBank under accession number
MT109313. DNA isolation, amplification, and sequence analysis
was carried out using an adaption of existing protocols (Supporting
Information).19 All microbial strains for antimicrobial testing were
obtained from ATCC (Table S2 of the Supporting Information).
Medium Selection and Fermentation. For this microbe,
optimization of culture media was carried out to improve the
production and increase the diversity of secondary metabolites. P.
aeruginosa BD06-03 was initially grown on TSA media and inoculated
into five 250 mL conical flasks containing 50 mL of different liquid
medium including TSB, PDB, NB, ISP4, and CZB separately (Figure
S2). Then the microbe was grown in a shaking incubator, shaking at
200 rpm at 30 °C for 4 days. After 4 days, CH2Cl2 was used to extract
the fermentation broth three times, and then then the extract was
evaporated and concentrated by a rotary evaporator. Using 4 mL of
MeOH, the residue was redissolved and 0.5 mL removed for HPLC
analysis. HPLC analysis was performed with a standard analytical
method using a reversed-phase C18 column (ZORBAX SB-C18, 4.6 ×
150 mm, 3.5 μm; Agilent Technologies, USA).
2-(2-Hydroxynonyl)-4-quinolone (5): colorless solid; [α]D +5.2 (c
0.05, MeOH); UV−vis (CH3OH) λmax (log ε) 234 (2.35), 314
1
(2.03), and 328 (1.91) nm; H NMR (methanol-d4, 600 MHz) and
13C NMR (methanol-d4, 150 MHz) spectra, see Table 1; HRESI-
(+)MS m/z 288.1963 [M + H]+ (calcd for C18H26NO2, 288.1964).
2-(E-Non-4-enyl)-4-quinolone (6): colorless solid; UV−vis
1
(CH3OH) λmax (log ε) 231 (2.03) and 314 (1.05) nm; H NMR
(CDCl3, 600 MHz) and 13C NMR (CDCl3, 150 MHz) spectra, see
Table 1; HRESI(+)MS m/z 561.3457 [2M + Na]+ (calcd for
C36H46N2O2Na, 561.3457).
ASSOCIATED CONTENT
* Supporting Information
The Supporting Information is available free of charge at
■
sı
Based on the optimization results for the culture media, ISP4
medium (composed of casein 10 g, KH2PO4 1.0 g, MgSO4 0.49 g,
NaCl 1.0 g, (NH4)2SO4 2.0 g, trace element solution 1.0 mL) was
selected as the most suitable culture medium for maximum
production of secondary metabolites in a large-scale culture. P.
aeruginosa BD06-03 was inoculated into 1 L of ISP4 medium (× 10
flasks) and incubated in a rotary incubator shaker, shaking at 200 rpm
at 30 °C for 7 days.
HPLC data for BD06-03 grown in various media, a
phylogenetic tree showing closely related microbes,
experimental data for known compounds, synthetic
procedures, precursor incubation studies, and NMR
and MS data for all isolated compounds (PDF)
Extraction and Separation. After 7 days of cultivation, all
culture flasks were combined and extracted with equal volumes of
CH2Cl2, EtOAc, and n-butanol (BuOH) three times each (10 L total
each). The solvent was removed under vacuum (Savant SC 210A,
Ameritech) to yield dry solvent extracts: CH2Cl2 extract (1.1 g),
EtOAc extract (0.5 g), and BuOH extract (0.8 g).
The CH2Cl2 extract (1.1 g) was fractionated through HP-20 resin
in an open column, eluting with H2O−MeOH by a stepwise elution
gradient (100:0, 80:20, 60:40, 40:60, 20:80, 0:100). Fractions of 60%
MeOH (Fr.1), 80% MeOH (Fr. 2), and 100% MeOH (Fr.3) were
selected as the primary fractions for the continued separation.
Fr.2 (185 mg) was fractionated again through HP-20 resin open
column chromatography, eluting with H2O−MeOH by a four-step
elution gradient (60:40, 40:60, 20:80, 0:100), to give four subfractions
(Fr.2-1, Fr.2-2, Fr 2-3, and Fr.2-4). Then subfractions Fr.2-2 and Fr.2-
3 were separated by semipreparative HPLC (MeCN−H2O, 15:85,
isocratic elution) to yield compounds 1 (1.0 mg), compound 3 (1.1
mg), and compound 4 (0.8 mg).
Fr.3 (1.4 g) was subjected to silica gel column chromatography,
eluting with CH2Cl2−MeOH (100:0 → 0:100), to afford seven
subfractions (Fr.3-1 to Fr.3-5). Subfractions Fr.3-2, Fr.3-3, and Fr.3-4
were purified by semipreparative HPLC (ZORBAX SB-C18), eluting
with 25% MeCN for 20 min and 38% MeCN for 25 min, then 44%
MeCN for 30 min and then 55% MeCN for 15 min, then 20 min to
100% MeCN for 30 min to yield compound 2 (1.0 mg), compound 5
(0.7 mg), compound 6 (1.8 mg), and a range of known compounds
(Supporting Information)
AUTHOR INFORMATION
Corresponding Author
■
Benjamin R. Clark − School of Pharmaceutical Science and
Technology, Tianjin University, Tianjin 300092, People’s
Republic of China; orcid.org/0000-0001-8987-7092;
Authors
Jianye Li − School of Pharmaceutical Science and Technology,
Tianjin University, Tianjin 300092, People’s Republic of China
Weiwei Sun − School of Pharmaceutical Science and Technology,
Tianjin University, Tianjin 300092, People’s Republic of China
Muhammad Saalim − School of Pharmaceutical Science and
Technology, Tianjin University, Tianjin 300092, People’s
Republic of China
Guixiang Wei − School of Pharmaceutical Science and
Technology, Tianjin University, Tianjin 300092, People’s
Republic of China
Diana A. Zaleta-Pinet − School of Pharmaceutical Science and
Technology, Tianjin University, Tianjin 300092, People’s
Republic of China
Complete contact information is available at:
2-(E-2-Methylthiovinyl)-4-quinolone (1): colorless solid; UV−vis
(CH3OH) λmax (log ε) 228 (2.38), 288 (2.71), and 328 (1.58) nm;
1H NMR (d6-DMSO, 600 MHz) and 13C NMR (d6-DMSO, 150
MHz) spectra, see Table 1; HRESI(+)MS m/z 240.0457 [M + Na]+
(calcd for C12H11NNaOS, 240.0459).
2-(5-Methylhexyl)-4-quinolone (2): colorless solid; UV−vis
(CH3OH) λmax (log ε) 234 (2.14), 314 (1.32), and 326 (0.89) nm;
1H NMR (CDCl3, 600 MHz) and 13C NMR (CDCl3, 150 MHz)
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
This work was funded in part by the award from the Research
Fund for International Young Scientists (81850410550) from
the National Science Foundation of China.
D
J. Nat. Prod. XXXX, XXX, XXX−XXX